Managing people with Type 2 diabetes in a post COVID-19 lockdown setting. What can GLP-1 receptor agonists offer?
This is a promotional symposium for UK Healthcare professionals. organised and funded by Novo Nordisk. Novo Nordisk products will be discussed. Please note this session is not eligible for accreditation.
Professor Melanie Davies, Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust will provide an overview of the latest data on the impact of Covid 19 on patients, and the role that GLP-1RA’s can play in the management of type 2 diabetes.
Please note this session is not eligible for accreditation.
Prescribing information and adverse event reporting can be found within the session and on the Novo Nordisk Exhibition stand.
Scan the QR code to register your consent to receive communications from Novo Nordisk. Communications may include promotional materials.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Stores. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 0232573). Calls may be monitored for training purposes.
UK21RYB0025, Date of prep: November 2021
-(002).jpg){kind=logo}
